Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Nabil P. Rizk, MD, MS, MPH

Advertisement

Articles by Nabil P. Rizk, MD, MS, MPH

Nabil P. Rizk, MD, MS, MPH

Dr. Rizk on the Evolution of Surgery in Lung Cancer

ByNabil P. Rizk, MD, MS, MPH
November 7th 2020

Nabil P. Rizk, MD, MS, MPH, discusses the evolving role of surgery in lung cancer.

Dr. Rizk on the Role of Surgery in Nonmetastatic Lung Cancer

ByNabil P. Rizk, MD, MS, MPH
December 23rd 2019

Nabil P. Rizk, MD, MS, MPH, discusses the role of anatomic surgical resection in nonmetastatic lung cancer.

Dr. Rizk on Eligibility Criteria for Surgical Resection in Lung Cancer

ByNabil P. Rizk, MD, MS, MPH
December 9th 2019

Nabil P. Rizk, MD, MS, MPH, discusses criteria for surgical resection in lung cancer.

Advertisement

Latest Updated Articles

  • Nabil P. Rizk, MD, MS, MPH
    Dr. Rizk on the Evolution of Surgery in Lung Cancer

    November 7th 2020

  • Dr. Rizk on Eligibility Criteria for Surgical Resection in Lung Cancer
    Dr. Rizk on Eligibility Criteria for Surgical Resection in Lung Cancer

    December 9th 2019

  • Dr. Rizk on the Role of Surgery in Nonmetastatic Lung Cancer
    Dr. Rizk on the Role of Surgery in Nonmetastatic Lung Cancer

    December 23rd 2019



Advertisement
Advertisement

Trending on OncLive

1

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

2

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC

3

Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC

4

Sonrotoclax Approval Generates New Options and Possibilities for R/R MCL

5

Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us